aluates Reports

$ 0.0

Automative

Polio Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: March 2024

Report Code: QYRE-Auto-18B4237

Global Polio Vaccine Market Research Report 2021

BUY CHAPTERS

Polio Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18B4237

Report

March 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Polio Vaccine - Market Size

The global market for Polio Vaccine was estimated to be worth US$ 709.8 million in 2023 and is forecast to a readjusted size of US$ 949.9 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030

Polio Vaccine - Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polio Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polio Vaccine by region & country, by Type, and by Application.

The Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccine.

Market Segmentation

Scope of Polio Vaccine - Market Report

Report Metric	Details
Report Name	Polio Vaccine - Market
Forecasted market size in 2030	US$ 949.9 million
CAGR	4.2%
Forecasted years	2024 - 2030
Segment by Type:	Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV)
Segment by Application	Public Private
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polio Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polio Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Polio Vaccine - Market size in 2030?

Ans: The Polio Vaccine - Market size in 2030 will be US$ 949.9 million.

Who are the main players in the Polio Vaccine - Market report?

Ans: The main players in the Polio Vaccine - Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Polio Vaccine - Market report?

Ans: The Applications covered in the Polio Vaccine - Market report are Public, Private

What are the Type segmentation covered in the Polio Vaccine - Market report?

Ans: The Types covered in the Polio Vaccine - Market report are Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)

1 Market Overview

1.1 Polio Vaccine Product Introduction

1.2 Global Polio Vaccine Market Size Forecast

1.2.1 Global Polio Vaccine Sales Value (2019-2030)

1.2.2 Global Polio Vaccine Sales Volume (2019-2030)

1.2.3 Global Polio Vaccine Sales Price (2019-2030)

1.3 Polio Vaccine Market Trends & Drivers

1.3.1 Polio Vaccine Industry Trends

1.3.2 Polio Vaccine Market Drivers & Opportunity

1.3.3 Polio Vaccine Market Challenges

1.3.4 Polio Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Polio Vaccine Players Revenue Ranking (2023)

2.2 Global Polio Vaccine Revenue by Company (2019-2024)

2.3 Global Polio Vaccine Players Sales Volume Ranking (2023)

2.4 Global Polio Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Polio Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Polio Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Polio Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Polio Vaccine

2.9 Polio Vaccine Market Competitive Analysis

2.9.1 Polio Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Polio Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Inactivated Polio Vaccine (IPV)

3.1.2 Oral Polio Vaccine (OPV)

3.2 Global Polio Vaccine Sales Value by Type

3.2.1 Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Polio Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Polio Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Polio Vaccine Sales Volume by Type

3.3.1 Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Polio Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Polio Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Polio Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Public

4.1.2 Private

4.2 Global Polio Vaccine Sales Value by Application

4.2.1 Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Polio Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Polio Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Polio Vaccine Sales Volume by Application

4.3.1 Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Polio Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Polio Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Polio Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Polio Vaccine Sales Value by Region

5.1.1 Global Polio Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Polio Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Polio Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Polio Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Polio Vaccine Sales Volume by Region

5.2.1 Global Polio Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Polio Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Polio Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Polio Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Polio Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Polio Vaccine Sales Value, 2019-2030

5.4.2 North America Polio Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Polio Vaccine Sales Value, 2019-2030

5.5.2 Europe Polio Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Polio Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Polio Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Polio Vaccine Sales Value, 2019-2030

5.7.2 South America Polio Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Polio Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Polio Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Polio Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Polio Vaccine Sales Value

6.2.1 Key Countries/Regions Polio Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Polio Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Polio Vaccine Sales Value, 2019-2030

6.3.2 United States Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Polio Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Polio Vaccine Sales Value, 2019-2030

6.4.2 Europe Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Polio Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Polio Vaccine Sales Value, 2019-2030

6.5.2 China Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Polio Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Polio Vaccine Sales Value, 2019-2030

6.6.2 Japan Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Polio Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Polio Vaccine Sales Value, 2019-2030

6.7.2 South Korea Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Polio Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Polio Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Polio Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Polio Vaccine Sales Value, 2019-2030

6.9.2 India Polio Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Polio Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sanofi

7.1.1 Sanofi Company Information

7.1.2 Sanofi Introduction and Business Overview

7.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sanofi Polio Vaccine Product Offerings

7.1.5 Sanofi Recent Development

7.2 GSK

7.2.1 GSK Company Information

7.2.2 GSK Introduction and Business Overview

7.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GSK Polio Vaccine Product Offerings

7.2.5 GSK Recent Development

7.3 Bibcol

7.3.1 Bibcol Company Information

7.3.2 Bibcol Introduction and Business Overview

7.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Bibcol Polio Vaccine Product Offerings

7.3.5 Bibcol Recent Development

7.4 Serum Institute

7.4.1 Serum Institute Company Information

7.4.2 Serum Institute Introduction and Business Overview

7.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Serum Institute Polio Vaccine Product Offerings

7.4.5 Serum Institute Recent Development

7.5 Tiantan Biological

7.5.1 Tiantan Biological Company Information

7.5.2 Tiantan Biological Introduction and Business Overview

7.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Tiantan Biological Polio Vaccine Product Offerings

7.5.5 Tiantan Biological Recent Development

7.6 IMBCA

7.6.1 IMBCA Company Information

7.6.2 IMBCA Introduction and Business Overview

7.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 IMBCA Polio Vaccine Product Offerings

7.6.5 IMBCA Recent Development

7.7 Panacea Biotec Ltd

7.7.1 Panacea Biotec Ltd Company Information

7.7.2 Panacea Biotec Ltd Introduction and Business Overview

7.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Panacea Biotec Ltd Polio Vaccine Product Offerings

7.7.5 Panacea Biotec Ltd Recent Development

7.8 Bio-Med

7.8.1 Bio-Med Company Information

7.8.2 Bio-Med Introduction and Business Overview

7.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bio-Med Polio Vaccine Product Offerings

7.8.5 Bio-Med Recent Development

7.9 Halfkin Bio-Pharmaceuticals

7.9.1 Halfkin Bio-Pharmaceuticals Company Information

7.9.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview

7.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offerings

7.9.5 Halfkin Bio-Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Polio Vaccine Industrial Chain

8.2 Polio Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Polio Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Polio Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi

GSK

Bibcol

Serum Institute

Tiantan biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

List of Tables

Table 1. Polio Vaccine Market Trends

Table 2. Polio Vaccine Market Drivers & Opportunity

Table 3. Polio Vaccine Market Challenges

Table 4. Polio Vaccine Market Restraints

Table 5. Global Polio Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Polio Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Polio Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Polio Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Polio Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Polio Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Polio Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Polio Vaccine

Table 13. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Polio Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Polio Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Polio Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Polio Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Polio Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Polio Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Polio Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Polio Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Polio Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Polio Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Polio Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Polio Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Polio Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Polio Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Polio Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Polio Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Polio Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Polio Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Polio Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Polio Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Polio Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Polio Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Polio Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Polio Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Polio Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Polio Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Polio Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Polio Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Polio Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Polio Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Polio Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Polio Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Polio Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Polio Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Polio Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Polio Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Polio Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Polio Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Polio Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Polio Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Polio Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Sanofi Company Information

Table 58. Sanofi Introduction and Business Overview

Table 59. Sanofi Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sanofi Polio Vaccine Product Offerings

Table 61. Sanofi Recent Development

Table 62. GSK Company Information

Table 63. GSK Introduction and Business Overview

Table 64. GSK Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. GSK Polio Vaccine Product Offerings

Table 66. GSK Recent Development

Table 67. Bibcol Company Information

Table 68. Bibcol Introduction and Business Overview

Table 69. Bibcol Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Bibcol Polio Vaccine Product Offerings

Table 71. Bibcol Recent Development

Table 72. Serum Institute Company Information

Table 73. Serum Institute Introduction and Business Overview

Table 74. Serum Institute Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Serum Institute Polio Vaccine Product Offerings

Table 76. Serum Institute Recent Development

Table 77. Tiantan Biological Company Information

Table 78. Tiantan Biological Introduction and Business Overview

Table 79. Tiantan Biological Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Tiantan Biological Polio Vaccine Product Offerings

Table 81. Tiantan Biological Recent Development

Table 82. IMBCA Company Information

Table 83. IMBCA Introduction and Business Overview

Table 84. IMBCA Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. IMBCA Polio Vaccine Product Offerings

Table 86. IMBCA Recent Development

Table 87. Panacea Biotec Ltd Company Information

Table 88. Panacea Biotec Ltd Introduction and Business Overview

Table 89. Panacea Biotec Ltd Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Panacea Biotec Ltd Polio Vaccine Product Offerings

Table 91. Panacea Biotec Ltd Recent Development

Table 92. Bio-Med Company Information

Table 93. Bio-Med Introduction and Business Overview

Table 94. Bio-Med Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Bio-Med Polio Vaccine Product Offerings

Table 96. Bio-Med Recent Development

Table 97. Halfkin Bio-Pharmaceuticals Company Information

Table 98. Halfkin Bio-Pharmaceuticals Introduction and Business Overview

Table 99. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offerings

Table 101. Halfkin Bio-Pharmaceuticals Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Polio Vaccine Downstream Customers

Table 105. Polio Vaccine Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Polio Vaccine Product Picture

Figure 2. Global Polio Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Polio Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Polio Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Polio Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Polio Vaccine Report Years Considered

Figure 7. Global Polio Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Polio Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Polio Vaccine Revenue in 2023

Figure 10. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Inactivated Polio Vaccine (IPV) Picture

Figure 12. Oral Polio Vaccine (OPV) Picture

Figure 13. Global Polio Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Polio Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Polio Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Polio Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Polio Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Public

Figure 19. Product Picture of Private

Figure 20. Global Polio Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Polio Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Polio Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Polio Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Polio Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Polio Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Polio Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Polio Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Polio Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Polio Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Polio Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Polio Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Polio Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Polio Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Polio Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Polio Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Polio Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Polio Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Polio Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Polio Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Polio Vaccine Industrial Chain

Figure 59. Polio Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions